Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2269051rdf:typepubmed:Citationlld:pubmed
pubmed-article:2269051lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:2269051lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:2269051lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:2269051lifeskim:mentionsumls-concept:C0396565lld:lifeskim
pubmed-article:2269051pubmed:issue7lld:pubmed
pubmed-article:2269051pubmed:dateCreated1991-2-20lld:pubmed
pubmed-article:2269051pubmed:abstractText118 surgical specimens were obtained from patients with lung cancer treated in our hospital during the period of 1977-1983 and tested with carcinoembryonic antigen (CEA), ABO (H) isoantigen and Concanavalin A (ConA). The results showed that the CEA assessment, which give no prognostic significance for long-term survival (P greater than 0.05), would be useful in predicting short-term (6 month) out come (P less than 0.05). All patients with positive ABO (H) test for squamous cell lung carcinoma survived at the end of five years. As for ConA, no definite link has been found with the prognosis.lld:pubmed
pubmed-article:2269051pubmed:languagechilld:pubmed
pubmed-article:2269051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2269051pubmed:citationSubsetIMlld:pubmed
pubmed-article:2269051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2269051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2269051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2269051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2269051pubmed:statusMEDLINElld:pubmed
pubmed-article:2269051pubmed:monthJullld:pubmed
pubmed-article:2269051pubmed:issn0529-5815lld:pubmed
pubmed-article:2269051pubmed:authorpubmed-author:ZhangY FYFlld:pubmed
pubmed-article:2269051pubmed:issnTypePrintlld:pubmed
pubmed-article:2269051pubmed:volume28lld:pubmed
pubmed-article:2269051pubmed:ownerNLMlld:pubmed
pubmed-article:2269051pubmed:authorsCompleteYlld:pubmed
pubmed-article:2269051pubmed:pagination424-6, 446-7lld:pubmed
pubmed-article:2269051pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:meshHeadingpubmed-meshheading:2269051-...lld:pubmed
pubmed-article:2269051pubmed:year1990lld:pubmed
pubmed-article:2269051pubmed:articleTitle[Immunopathological factors influencing the prognosis after resection of lung cancer].lld:pubmed
pubmed-article:2269051pubmed:affiliationQingdao Medical College.lld:pubmed
pubmed-article:2269051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2269051pubmed:publicationTypeEnglish Abstractlld:pubmed